This topic contains a solution. Click here to go to the answer

Author Question: A youthful heroin addict with a co-occurrence of mental illness visits a primary care doctor within ... (Read 106 times)

ENagel

  • Hero Member
  • *****
  • Posts: 540
A youthful heroin addict with a co-occurrence of mental illness visits a primary care doctor within her parent's managed care network. This is an example of ________.
 
  A. an HMO
  B. a PPO
  C. a POS
  D. Medicaid

Question 2

An alcoholic visits a chemical dependency professional outside of his managed care network. He must pay more, but the insurance company will pay a portion. This is an example of ________.
 
  A. an HMO
  B. a PPO
  C. a POS
  D. Medicaid



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yuyiding

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

A

Answer to Question 2

B




ENagel

  • Member
  • Posts: 540
Reply 2 on: Jun 19, 2018
YES! Correct, THANKS for helping me on my review


patma1981

  • Member
  • Posts: 292
Reply 3 on: Yesterday
Excellent

 

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library